Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K Macaulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin
Journal of psychopharmacology (Oxford, England) August 1, 2017 DOI: 10.1177/0269881117711712 via PubMed
Summary
AI-generated from the abstractTraumatic events can lead to lasting personality changes, especially increased neuroticism. In a randomized trial of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD, changes in openness—but not neuroticism—moderated the link between reduced PTSD symptoms and the treatment. Patients showed increased openness and decreased neuroticism from baseline to long-term follow-up. These preliminary findings suggest MDMA-assisted psychotherapy may alter personality structure beyond just relieving PTSD symptoms, leading to enduring personality change.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Adults with chronic, treatment-resistant PTSD |
| Intervention | MDMA-assisted psychotherapy |
| Duration | Long-term follow-up |
| Topics | MDMA |
| Keywords | Neo personality Openness Pharmacotherapy Lasting |
| Citations | 163 |
| Key finding | Changes in openness, but not neuroticism, moderated the relationship between reduced PTSD symptoms and MDMA-assisted psychotherapy, with increased openness and decreased neuroticism observed at long-term follow-up. |
Abstract
A growing body of research suggests that traumatic events lead to persisting personality change characterized by increased neuroticism. Relevantly, enduring improvements in Post-Traumatic Stress Disorder (PTSD) symptoms have been found in response to 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy. There is evidence that lasting changes in the personality feature of "openness" occur in response to hallucinogens, and that this may potentially act as a therapeutic mechanism of change. The present study investigated whether heightened Openness and decreased Neuroticism served as a mechanism of change within a randomized trial of MDMA-assisted psychotherapy for chronic, treatment-resistant PTSD. The Clinician-Administered PTSD Scale (CAPS) Global Scores and NEO PI-R Personality Inventory (NEO) Openness and Neuroticism Scales served as outcome measures. Results indicated that changes in Openness but not Neuroticism played a moderating role in the relationship between reduced PTSD symptoms and MDMA treatment. Following MDMA-assisted psychotherapy, increased Openness and decreased Neuroticism when comparing baseline personality traits with long-term follow-up traits also were found. These preliminary findings suggest that the effect of MDMA-assisted psychotherapy extends beyond specific PTSD symptomatology and fundamentally alters personality structure, resulting in long-term persisting personality change. Results are discussed in terms of possible mechanisms of psychotherapeutic change.